Lazarex Cancer Foundation and Oncopeptides Partner to Remove Financial Barriers to Oncopeptides’ sEAPort Expanded Access
This Marks the First Innovative Partnership between Lazarex and a Pharmaceutical Company for this Purpose DANVILLE, CALIFORNIA, UNITED STATES, October 2, 2020 /EINPresswire.com/ — Lazarex Cancer Foundation, an advocacy group dedicated to improving access to cancer clinical trials and Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announced …